Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-019017
Filing Date
2015-01-23
Accepted
2015-01-23 17:09:36
Documents
9
Period of Report
2015-03-19
Effectiveness Date
2015-01-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d829416ddef14a.htm DEF 14A 1205725
2 GRAPHIC g829416g00e27.jpg GRAPHIC 1818
3 GRAPHIC g829416g02h63.jpg GRAPHIC 1784
4 GRAPHIC g829416g04s40.jpg GRAPHIC 31389
5 GRAPHIC g829416g13d57.jpg GRAPHIC 16451
6 GRAPHIC g829416g26j97.jpg GRAPHIC 6464
7 GRAPHIC g829416g68u50.jpg GRAPHIC 5594
8 GRAPHIC g829416g91v63.jpg GRAPHIC 1825
9 GRAPHIC g829416img001.jpg GRAPHIC 14447
  Complete submission text file 0001193125-15-019017.txt   1317817
Mailing Address DAMASTOWN MULHUDDART DUBLIN L2 15
Business Address DAMASTOWN MULHUDDART DUBLIN L2 15 353 1 8808180
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-35803 | Film No.: 15546319
SIC: 2834 Pharmaceutical Preparations